MVIS US Listed Biotech 25 Index

The modified market cap-weighted index tracks the performance of the largest and most liquid US-listed companies that generate at least 50% of their revenues from biotechnology. The pure-play index contains only companies which are engaged primarily in research and development as well as production, marketing and sales of drugs based on genetic analysis and diagnostic equipment. The MVIS US Listed Biotech 25 Index (MVBBH) has been licensed to underlie financial products with currently USD 468.44 million in assets under management.

Components

The MVIS US Listed Biotech 25 Index counts currently 24 components. The full list of the components with the respective weights is available below.

Items 1-24 of total 24
ComponentCountryWeight
AMGEN INCUS13.94%
MODERNA INCUS8.54%
GILEAD SCIENCES INCUS7.12%
IQVIA HOLDINGS INCUS5.21%
ALEXION PHARMACEUTICALS INCUS5.05%
Regeneron Pharmaceuticals IncUS4.92%
Exact Sciences CorpUS4.76%
VERTEX PHARMACEUTICALS INCUS4.62%
Illumina IncUS4.54%
BIOGEN INCUS4.38%
SEAGEN INCUS3.99%
INCYTE CORPUS3.55%
Guardant Health, Inc.US3.45%
CHARLES RIVER LABORATORIESUS3.25%
BIOMARIN PHARMACEUTICAL INCUS2.95%
QIAGEN N.V.DE2.91%
Sarepta Therapeutics IncUS2.83%
BionTech SEDE2.60%
BeiGene Ltd. ADRCN2.57%
Alnylam Pharmaceuticals IncUS2.41%
NEUROCRINE BIOSCIENCES INCUS1.81%
NOVAVAX INCUS1.72%
QUIDEL CORPUS1.49%
Ionis Pharmaceuticals IncUS1.40%
Items 1-24 of total 24
Up